Reference1. Souders MC, Mason TBA, Valladares O, Bucan M, Levy SE, Mandell DS, Weaver TE, Pinto-Martin J. 2009; Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 32:12. 1566–1578.
https://doi.org/10.1093/sleep/32.12.1566
![]() ![]() ![]() 2. Hoshino Y, Watanabe H, Yashima Y, Kaneko M, Kumashiro H. 1984; An investigation on sleep disturbance of autistic children. Folia Psychiatr Neurol Jpn. 38:1. 45–51.
https://doi.org/10.1111/j.1440-1819.1984.tb00353.x
![]() ![]() 3. Liu X, Hubbard JA, Fabes RA, Adam JB. 2006; Sleep disturbances and correlates of children with autism spectrum disorders. Child Psychiatry Hum Dev. 37:2. 179–191.
https://doi.org/10.1007/s10578-006-0028-3
![]() ![]() 4. Taira M, Takase M, Sasaki H. 1998; Sleep disorder in children with autism. Psychiatry Clin Neurosci. 52:2. 182–183.
https://doi.org/10.1111/j.1440-1819.1998.tb01018.x
![]() ![]() 5. Malow BA, Marzec ML, Mcgrew SG, Wang L, Henderson LM, Stone WL. 2006; Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep. 29:12. 1563–1571.
https://doi.org/10.1093/sleep/29.12.1563
![]() ![]() 6. Cataldo MF, Harris J. 1982; The biological basis for self-injury in the mentally retarded. Analysis and Intervention in Developmental Disabilities. 2:1. 21–39.
https://doi.org/10.1016/0270-4684(82)90004-0
![]() 7. Bruni O, Angriman M, Melegari MG, Ferri R. 2019; Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opin Pharmacother. 20:18. 2257–2271.
https://doi.org/10.1080/14656566.2019.1674283
![]() ![]() 8. Pelayo R, Yuen K. 2012; Pediatric sleep pharmacology. Child Adolesc Psychiatr Clin N Am. 21:4. 861–883.
https://doi.org/10.1016/j.spen.2008.03.004
![]() ![]() 9. Kim MJ, Lee SH, Lee JY. 2015; A study on sleep habits of weak children groups. J Pediatr Korean Med. 29:4. 1–11.
https://doi.org/10.7778/jpkm.2015.29.4.001
10. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. 2008. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Medical Care. 46:11. 1125–1133.
http://www.jstor.org/stable/40221817
![]() 11. Angriman M, Caravale B. 2015; Sleep in children with neurodevelopmental disabilities. Neuropediatrics. 46:3. 199–210.
https://doi.org/10.1055/s-0035-1550151
![]() ![]() 12. Valicenti-McDermott M, Lawson K, Httinger K, Seijo R, Schechtman M, Shulman L, Shinnar S. 2019; Sleep problems in children with autism and other developmental disabilities: A brief report. J Child Neurol. 34:7. 387–393.
https://doi.org/10.1177/0883073819836541
![]() ![]() 13. Doran SM, Harvey MT, Horner RH. 2006; Sleep and developmental disabilities: Assessment, treatment and outcome measures. Ment Retard. 44:1. 13–27.
https://doi.org/10.1352/0047-6765(2006)44[13:SADDAT]2.0.CO;2
![]() ![]() 14. Hartx I, Furu K, Bratlid T, Handal M, Skurtveit S. 2012; Hypnotic drug use among 0–17year olds during 2004–2011: a nationwide prescription database study. Scand J Public Health. 40:8. 704–711.
https://doi.org/10.1177/1403494812464446
![]() ![]() 15. The Korean society of oriental neuropsychiatry. Oriental Neuropsychiatry. 3rd ed. Seoul: Jipmundang;2007. p. 235–248.
16. Park BR. The literature review on medication of insomnia. Master’s thesis. Wonkwang University;2010.
17. Park IS, No DJ, Lee GE, Jo HG, Kang HW, Ryu YS, Park BR. 2011; A case report of insomnia improved by jawon (ziuan)’s purgative action. J of Oriental Neuropsychiatry. 22:4. 125–134.
https://doi.org/10.7231/JON.2011.22.4.125
![]() 18. Shin HJ, Lee BR, Lee JH, Chang GT. 2017; A clinical study of treating autism spectrum disorder in childhood. J Pediatr Korean Med. 31:4. 49–60.
https://doi.org/10.7778/jpkm.2017.31.4.049
19. Deung PG, Park BH. Yuchwibanggwanguihaeseol. 1st ed. Seoul: Uibang Publishing Company;2007. p. 417–23.
20. Kim NE, Jo HR, Jee SY, Hwangbo M. 2017; 18 cases of rhinitis with nasal obstruction treated by gyulpidaehwangbakcho-tang. J Korean Med Ophthalmol Otolaryngol Dermatol. 30:3. 193–200.
https://doi.org/10.6114/jkood.2017.30.3.193
21. The Korean society of herbal medicine. Bonchohak. 3rd ed. Seoul: Yeongminsa;2014. p. 389–391. p. 393–395.
22. Ryu SH, Lim YH, Ryou SY, Yun YG. 2020. A study on applications of prescriptions including Fructus Ponciri Seu Aurantii as a main component in Dongeuibogam. Herbal Formula Science. 28:4. 313–325.
https://www.koreascience.or.kr/article/JAKO200824067118647.page
23. Tana WX, Li Y, Wang Y, Zhang ZJ, Wang T, Zhou Q, Wang XY. 2017; Anti-coagulative and gastrointestinal motility regulative activities of Fructus Aurantii Immaturus and its effective fractions. Biomed Pharmacother. 90:244–252.
https://doi.org/10.1016/j.biopha.2017.03.060
![]() ![]() 24. Kim JO. Yak-jing. 1st ed. Seoul: Koonja;2012. p. 54–63. p. 234–242.
25. Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D. 2012; Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J sleep Res. 21:6. 700–709.
https://doi.org/10.1111/j.1365-2869.2012.01021.x
![]() ![]() 26. Kim YR. 2010. A study on overall sleep characteristics, relationship between sleep characteristics and obesity in school aged children. 1st ed. Kyunggido: Master’s thesis of Hanshin University;2010.
|
|